BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 28412995)

  • 1. Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study.
    Thangaratinam S; Allotey J; Marlin N; Mol BW; Von Dadelszen P; Ganzevoort W; Akkermans J; Ahmed A; Daniels J; Deeks J; Ismail K; Barnard AM; Dodds J; Kerry S; Moons C; Riley RD; Khan KS
    Health Technol Assess; 2017 Apr; 21(18):1-100. PubMed ID: 28412995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models.
    Thangaratinam S; Allotey J; Marlin N; Dodds J; Cheong-See F; von Dadelszen P; Ganzevoort W; Akkermans J; Kerry S; Mol BW; Moons KG; Riley RD; Khan KS;
    BMC Med; 2017 Mar; 15(1):68. PubMed ID: 28356148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic model to guide decision-making on timing of delivery in late preterm pre-eclampsia: the PEACOCK prospective cohort study.
    Duhig K; Seed PT; Placzek A; Sparkes J; Gill C; Brockbank A; Shennan A; Thangaratinam S; Chappell LC
    Health Technol Assess; 2021 May; 25(30):1-32. PubMed ID: 34024312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of prediction models for risk of adverse outcomes in women with early-onset pre-eclampsia: protocol of the prospective cohort PREP study.
    Allotey J; Marlin N; Mol BW; Von Dadelszen P; Ganzevoort W; Akkermans J; Ahmed A; Daniels J; Deeks J; Ismail K; Barnard AM; Dodds J; Kerry S; Moons C; Khan KS; Riley RD; Thangaratinam S
    Diagn Progn Res; 2017; 1():6. PubMed ID: 31093538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria in pre-eclampsia: how much matters?
    Chan P; Brown M; Simpson JM; Davis G
    BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic models for identifying risk of poor outcome in people with acute ankle sprains: the SPRAINED development and external validation study.
    Keene DJ; Schlüssel MM; Thompson J; Hagan DA; Williams MA; Byrne C; Goodacre S; Cooke M; Gwilym S; Hormbrey P; Bostock J; Haywood K; Wilson D; Collins GS; Lamb SE
    Health Technol Assess; 2018 Nov; 22(64):1-112. PubMed ID: 30474592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model.
    Saleh L; Alblas MM; Nieboer D; Neuman RI; Vergouwe Y; Brussé IA; Duvekot JJ; Steyerberg EW; Versendaal HJ; Danser AHJ; Meiracker AHVD; Verdonk K; Visser W
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):698-704. PubMed ID: 33030757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis.
    Snell KIE; Allotey J; Smuk M; Hooper R; Chan C; Ahmed A; Chappell LC; Von Dadelszen P; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GCS; Ganzevoort W; Laivuori H; Odibo AO; Arenas Ramírez J; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJM; Vinter CA; Magnus P; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo SA; Browne JL; Moons KGM; Riley RD; Thangaratinam S;
    BMC Med; 2020 Nov; 18(1):302. PubMed ID: 33131506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia.
    Ukah UV; Payne B; Karjalainen H; Kortelainen E; Seed PT; Conti-Ramsden FI; Cao V; Laivuori H; Hutcheon J; Chappell L; Mark Ansermino J; Vatish M; Redman C; Lee T; Li L; Magee LA; von Dadelszen P;
    Pregnancy Hypertens; 2019 Jan; 15():42-50. PubMed ID: 30825926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal factors.
    Benkő Z; Chaveeva P; de Paco Matallana C; Zingler E; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 May; 53(5):649-654. PubMed ID: 30887621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis.
    Waugh J; Hooper R; Lamb E; Robson S; Shennan A; Milne F; Price C; Thangaratinam S; Berdunov V; Bingham J
    Health Technol Assess; 2017 Oct; 21(61):1-90. PubMed ID: 29064366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.
    Pilalis A; Souka AP; Antsaklis P; Daskalakis G; Papantoniou N; Mesogitis S; Antsaklis A
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):135-40. PubMed ID: 17221926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive performance of the competing risk model in screening for preeclampsia.
    Wright D; Tan MY; O'Gorman N; Poon LC; Syngelaki A; Wright A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Feb; 220(2):199.e1-199.e13. PubMed ID: 30447210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ; Manyame S; Medley N; Williams MJ
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011192. PubMed ID: 31523806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset.
    Akkermans J; Payne B; von Dadelszen P; Groen H; Vries Jd; Magee LA; Mol BW; Ganzevoort W
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():58-62. PubMed ID: 24965981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
    von Dadelszen P; Payne B; Li J; Ansermino JM; Broughton Pipkin F; Côté AM; Douglas MJ; Gruslin A; Hutcheon JA; Joseph KS; Kyle PM; Lee T; Loughna P; Menzies JM; Merialdi M; Millman AL; Moore MP; Moutquin JM; Ouellet AB; Smith GN; Walker JJ; Walley KR; Walters BN; Widmer M; Lee SK; Russell JA; Magee LA;
    Lancet; 2011 Jan; 377(9761):219-27. PubMed ID: 21185591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
    Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
    Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.
    Coleman MA; McCowan LM; North RA
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):7-12. PubMed ID: 10776006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.
    Payne BA; Hutcheon JA; Ansermino JM; Hall DR; Bhutta ZA; Bhutta SZ; Biryabarema C; Grobman WA; Groen H; Haniff F; Li J; Magee LA; Merialdi M; Nakimuli A; Qu Z; Sikandar R; Sass N; Sawchuck D; Steyn DW; Widmer M; Zhou J; von Dadelszen P;
    PLoS Med; 2014 Jan; 11(1):e1001589. PubMed ID: 24465185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.